According to GlaxoSmithKline's latest financial reports the company's total debt is $22.45 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $22.93 B | -9.83% |
2022-12-31 | $25.43 B | -22.04% |
2021-12-31 | $32.62 B | -11.83% |
2020-12-31 | $37.00 B | -7.49% |
2019-12-31 | $40.00 B | 20.92% |
2018-12-31 | $33.08 B | 43.24% |
2017-12-31 | $23.09 B | -0.46% |
2016-12-31 | $23.20 B | -5.86% |
2015-12-31 | $24.64 B | -15.72% |
2014-12-31 | $29.24 B | -2.83% |
2013-12-31 | $30.09 B | 1.74% |
2012-12-31 | $29.58 B | 27.98% |
2011-12-31 | $23.11 B | -0.84% |
2010-12-31 | $23.31 B | -11.39% |
2009-12-31 | $26.30 B | 10.89% |
2008-12-31 | $23.72 B | 12.85% |
2007-12-31 | $21.02 B | 95.02% |
2006-12-31 | $10.77 B | -14.86% |
2005-12-31 | $12.66 B | 10.65% |
2004-12-31 | $11.44 B | 25.52% |
2003-12-31 | $9.11 B | 56.5% |
2002-12-31 | $5.82 B | 9.46% |
2001-12-31 | $5.32 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Novartis NVS | $27.28 B | 21.48% | ๐จ๐ญ Switzerland |
Pfizer PFE | $70.84 B | 215.44% | ๐บ๐ธ USA |
Sanofi SNY | $20.36 B | -9.31% | ๐ซ๐ท France |
Merck MRK | $35.05 B | 56.08% | ๐บ๐ธ USA |
AstraZeneca AZN | $34.55 B | 53.84% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $20.15 B | -10.27% | ๐ฎ๐ฑ Israel |
Dynavax Technologies
DVAX | $0.25 B | -98.86% | ๐บ๐ธ USA |